Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome infiltration for prolonged analgesia after hemorrhoidectomy
ChiCTR2500103460Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine and lidocaine in hemorrhoid (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Cumulative pain score at rest within 72 hours after surgery. Planned start May 2025; status: not yet recruiting.
02
Drugs
bupivacainelidocaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2500103460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103460.